These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 32321079
21. Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape. Musicki B, Burnett AL. Expert Opin Ther Targets; 2020 May; 24(5):439-450. PubMed ID: 32191546 [Abstract] [Full Text] [Related]
22. Multisystem damage associated with tricorporal priapism in sickle cell disease. Sharpsteen JR, Powars D, Johnson C, Rogers ZR, Williams WD, Posch RJ. Am J Med; 1993 Mar; 94(3):289-95. PubMed ID: 8452153 [Abstract] [Full Text] [Related]
23. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. J Sex Med; 2009 Sep; 6(9):2494-504. PubMed ID: 19523035 [Abstract] [Full Text] [Related]
24. Evaluation of knowledge of priapism in sickle cell patients in Senegal. Gaye O, Seck M, Gueye M, Toure SA, Faye BF, Thiam NM, Jalloh M, Ndoye M, Niang L, Fall PA, Diop S. Int Urol Nephrol; 2023 Sep; 55(9):2169-2175. PubMed ID: 37165263 [Abstract] [Full Text] [Related]
25. The physical, social and psychological impact of priapism on adult males with sickle cell disorder. Addis G, Spector R, Shaw E, Musumadi L, Dhanda C. Chronic Illn; 2007 Jun; 3(2):145-54. PubMed ID: 18083669 [Abstract] [Full Text] [Related]
26. Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study. Cintho Ozahata M, Page GP, Guo Y, Ferreira JE, Dinardo CL, Carneiro-Proietti ABF, Loureiro P, Mota RA, Rodrigues DOW, Belisario AR, Maximo C, Flor-Park MV, Custer B, Kelly S, Sabino EC, International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III). J Sex Med; 2019 Dec; 16(12):1988-1999. PubMed ID: 31668730 [Abstract] [Full Text] [Related]
27. Knowledge, Experiences and Coping Mechanisms for Priapism among Persons with Sickle Cell Disease in Ibadan, Nigeria. Raji OH, Shokunbi WA, Ajuwon AJ. West Afr J Med; 2020 Dec; 37(1):32-39. PubMed ID: 32030709 [Abstract] [Full Text] [Related]
28. A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study. Olujohungbe AB, Adeyoju A, Yardumian A, Akinyanju O, Morris J, Westerdale N, Akenova Y, Kehinde MO, Anie K, Howard J, Brooks A, Davis VA, Khoriatry AI. J Androl; 2011 Dec; 32(4):375-82. PubMed ID: 21127308 [Abstract] [Full Text] [Related]
29. Priapism in sickle cell disease. Rogers ZR. Hematol Oncol Clin North Am; 2005 Oct; 19(5):917-28, viii. PubMed ID: 16214652 [Abstract] [Full Text] [Related]
30. Priapism and impotence in homozygous sickle cell disease. Emond AM, Holman R, Hayes RJ, Serjeant GR. Arch Intern Med; 1980 Nov; 140(11):1434-7. PubMed ID: 6159833 [Abstract] [Full Text] [Related]
31. [Priapism in sickle cell anaemia in Senegal: prevalence, attitudes and knowledge]. Gbadoé AD, Diagne I, Ilboudo A, Diop S, Géraldo A, Guédénon J, Akpako P. Bull Soc Pathol Exot; 2007 Aug; 100(3):179-81. PubMed ID: 17824310 [Abstract] [Full Text] [Related]
32. Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study. Tranekær S, Hansen DL, Biemond BJ, Sørensen AL, Glenthøj A, Petersen J, Frederiksen H. Ann Hematol; 2021 Aug; 100(8):1947-1951. PubMed ID: 34136949 [Abstract] [Full Text] [Related]
33. The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA Guideline. Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS, Mulhall JP, Oristaglio J, Rahimi LL, Rogers ZR, Terlecki RP, Trost L, Yafi FA, Bennett NE. J Urol; 2022 Jul; 208(1):43-52. PubMed ID: 35536142 [Abstract] [Full Text] [Related]
34. Erectile function and dysfunction following low flow priapism: a comparison of distal and proximal shunts. Tabibi A, Abdi H, Mahmoudnejad N. Urol J; 2010 Jul; 7(3):174-7. PubMed ID: 20845293 [Abstract] [Full Text] [Related]
35. Priapism in sickle cell anemia in Togo: prevalence and knowledge of this complication. Gbadoé AD, Dogba A, Ségbéna AY, Nyadanu M, Atakouma Y, Kusiaku K, Vovor A, Assimadi JK. Hemoglobin; 2001 Nov; 25(4):355-61. PubMed ID: 11791867 [Abstract] [Full Text] [Related]
36. Priapism in sickle cell disease: the case for early implantation of the penile prosthesis. Monga M, Broderick GA, Hellstrom WJ. Eur Urol; 1996 Nov; 30(1):54-9. PubMed ID: 8854068 [Abstract] [Full Text] [Related]
37. Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature. Anele UA, Mack AK, Resar LMS, Burnett AL. Int Urol Nephrol; 2014 Sep; 46(9):1733-1736. PubMed ID: 24824148 [Abstract] [Full Text] [Related]